| Progress In Mind

Hjem

Satellite symposium

Improving treatment outcomes in schizophrenia: Looking beyond positive symptoms for early and effective intervention

Although the symptoms of schizophrenia are troublesome for almost all persons with the disease, its...

Congress highlights

Challenges and perspectives in the management of major depressive disorder: How can we bridge clinical predictors and biomarkers to better treatment outcomes for more patients?

Although the past 50 to 60 years of antidepressant drug development focusing on monoamines has...

Depression: the unmet needs

Watch our new video series: ‘Depression: the unmet needs’ as Dr Diane McIntosh of the...

John FP Bridges - Changing the paradigm: putting patient treatment goals at the center

Congress highlights

Early effects of antidepressants – a clue to mechanism of action

The delay in onset of effect of antidepressant treatment can be frustrating both for the patient...

Congress highlights

The Lancet Psychiatry Commission: A blueprint for protecting physical health in people with mental illness

The Lancet Psychiatry Commission: A blueprint for protecting physical health in people with mental...

What do clinical goals mean to patients with schizophrenia?

Satellite symposium

Patient goals and measuring outcome crucial in MDD

Asking people what they most want from depression treatment, treating to target, measurement-based...

Congress highlights

Can we be bothered about apathy? Approaching negative symptoms in schizophrenia

There has been an increased interest in research for the negative symptoms of schizophrenia over...

Satellite symposium

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Improving adherence and reducing rates of relapse and rehospitalization are of paramount importance...

Congress highlights

Immune modulation in psychiatric disorders: Are we there yet?

It has been argued that drug discovery for psychiatric disorders is at a near standstill. Which...

Satellite symposium

Treatment outcomes in schizophrenia – what matters to patients?

Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression...

Medisinsk ressurssenter

Lundbeck Institute Campus

Et medisinsk ressurssenter innen psykiatri og nevrologi.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind България Continue to Progress in Mind Spain Continue to Progress in Mind Ireland

Du forlater Progress in Mind

Cancel

Du forlater

Progress in Mind Norge

For å tilgang til alt innholdet på denne nettsiden må du registrere deg.

Hvis du ikke befinner deg i Norge, klikk her.

LOGG INN REGISTRER

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

Informasjonen på dette nettstedet er utelukkende ment for helsepersonell

JA – Jeg er helsepersonell

NEI – Jeg er ikke helsepersonell